New Digital Imaging Technologies
Regulator OKs DeepBio’s AI-based Prostate Cancer Pathology Di...
DeepBio said its DeepDx-Prostate Pro, an artificial intelligence (AI)-based pathology diagnosis assistance software, has received a Class 3 in-vitro diagnostic medical device from the Ministry of Food and Drug Safety. According to the...
10 - 14 November 2021 In-Person and Online Booth 209 The team at Indica Labs would like to invite you to stop by booth #209 at SITC to learn more about the latest in our HALO®, HALO AI™, HALO Link™, and HALO AP® image analysis...
Aiforia Announces Virtual Workshop
Aiforia has announced its latest virtual workshop. Practical applications of AI from research to clinical practice November 8th 12pm to 3pm EST (Boston) Join our free virtual workshop to hear from speakers at Memorial Sloan Kettering Cancer...
Through its PMA.core software, Pathomation provides a universal image management solution. Its latest release offers the most versatile options for storage available yet. ANTWERP, BELGIUM (PRWEB) NOVEMBER 02, 2021 Digital pathology insiders...
Artificial Intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment. Collaboration with PathAI expands pathologist access to...
Paige Prostate was granted de novo marketing authorization from the FDA to aid in the primary diagnosis of prostate cancer. NEW YORK--(BUSINESS WIRE)--Paige, the global leader in AI-based diagnostic software in pathology, today announced...